Organization type


  • Foundation

Early phases


  • Biomarker identification
  • Omics
  • Target identification – new biological hypothesis
  • Target validation – Hypothesis verification

Screening


  • Assay development
  • Chemical libraries
  • Screening and high throughput screening using small molecules (including natural product, DNA encoded libraries and fragment libraries)

Optimization phases


  • In vitro biochemical models(including assay/model development and testing)
  • In vitro cellular and organotypic 3D models (including assay/model development and testing)
  • Mechanism of action (MoA) assessment
  • Medicinal chemistry programs for hit to lead and lead optimization

Functional areas


  • Molecular and cellular biology

Terapeutic areas


  • Autoimmunity / Inflammation
  • Blood and lymphatic system
  • Cancer
  • Cardiovascular
  • Dermatology
  • Infectious diseases
  • Metabolism / Endocrinology
  • Nervous Central System
  • Ophthalmology / Optometry
  • Rare diseases

Additional activities


  • Consulting services